跳至主要内容
临床试验/JPRN-jRCTs031180231
JPRN-jRCTs031180231已完成未知

Multi-center randomized controlled trial to evaluate oral vitamin B12 treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients

Rino Yasushi0 个研究点目标入组 78 人开始时间: 2019年3月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
78

研究概览

简要总结

The major findings of this study were that oral Vitamin B12 50010^-6g/day replacement is as effective and safe as oral Vitamin B12 150010^-6g/day replacement for Vitamin B12 deficiency.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1:Histologically proven adenocarcinoma of the stomach and dignosed pathological stage I to III
  • 2:Received R0 resection
  • 3:Age ranging between 20 and 80 years
  • 4:ECOG performance status 0-2
  • 5:seremu vitamin B12 was under 200pg/ml
  • 6:Peripheral neuropathy with vitamin B12
  • 7:Sufficient oral intake
  • 8:Sufficient organ function
  • 9:Answer toPNQ test
  • 10:Patients were given a written explanation of the study protocol and provided their written informed consent before participating.

排除标准

  • 1:Synchronous or metachronous cancer (synchronous multiple cancers in the stomach included).
  • 2:Allergic reaction to vitamin B12
  • 3:Systemic treatment with vitamin B12
  • 4:Peripheral neuropathy with other causes
  • 5:Received adjuvant chemotherapy for gastric cancer
  • 6:Any other medical conditions that made a patient unsuitable for inclusion in the study according to the opinion of the investigator were also considered to be exclusion criteria for this study
  • 7:Other patients judged inappropriate by the examining physician

研究者

发起方
Rino Yasushi

相似试验